Mathew Pendo
CIK: 0001603759
Transaction Breakdown
Open Market Buys (P)1 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Pendo Mathew
Pendo Mathew (SEC CIK 0001603759) files insider reports with the SEC as President of Oaktree Specialty Lending Corp (OCSL) and Chief Operating Officer of Oaktree Acquisition Corp. III Life Sciences (OACC).
Signal8 holds 2 ownership filings by Pendo Mathew (1 Form 3, 1 Form 4), filed between Oct 23, 2024 and Feb 25, 2025. Those filings report 1 transaction, the latest on Feb 24, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Pendo Mathew's filings is in LOS ANGELES, CA.
Recent filings by Pendo Mathew
- Feb 24, 2025: Open-market purchase of OCSL shares (Form 4, code P).
Other insiders filing for Oaktree Specialty Lending Corp (OCSL)
- Panossian Armen
- CALDWELL PHYLLIS R, Director
- Gero Deborah Ann, Director
- McKeone Brett, Chief Operating Officer
- Jacobson Craig A, Director
- Khanna Raghav, Co-Chief Investment Officer